文献速递乳腺MR

磁共振引导下真空辅助大体积乳腺活检(MR引导VALB)的安全性与有效性

Safety and Efficacy of Magnetic Resonance-Guided Vacuum-Assisted Large-Volume Breast Biopsy (MR-Guided VALB).
PubMed 文献 · Invest Radiol · 2017-01-01

对865例患者1414个仅MRI可见乳腺病灶行1.5 T系统9G磁共振引导下真空辅助大体积活检,每病灶至少取24条组织。技术成功率达病灶99.7%、患者99.5%,失败与病灶位置、乳腺大小、病灶大小及类型无关;无重大并发症,良性诊断者随访2年活检部位均未发生乳腺癌。

要点

  • MR引导VALB对1414个MRI-only病灶的技术成功率为99.7%,患者水平为99.5%。
  • 原发技术失败仅0.1%病灶(2/1414),影像-病理不符提示假阴性者0.3%病灶(4/1412)。
  • 失败可能性与病灶位于中央或外周、乳腺大小、病灶大小及NME或ME类型均无关。

核心结论

  • 磁共振引导VALB是安全操作,成功率高达99.7%,且不依赖靶病灶大小、类型、位置或乳腺大小,并发症率极低。

研究设计与样本

  • 经机构审查委员会批准的分析,纳入865例患者共1414个仅MRI可见乳腺病灶,在1.5 T系统上以9G系统行MR引导VALB,每靶病灶至少采集24条组织。

关键影像表现/征象

  • 靶病灶位于乳腺中央部者占66.6%(941/1414),位于外周部者占33.6%(473/1414)。
  • 靶病灶位于大、中、小乳腺者分别占22.7%(321/1414)、56.4%(797/1414)、20.9%(296/1414)。
  • 靶病灶为无肿块强化(NME)者占64.0%(905/1414),为肿块强化(ME)者占36.0%(509/1414),NME平均大小23 mm,ME平均大小9 mm。
  • 活检后即刻控制影像上靶病灶表现为完全或至少大部分被去除,活检槽朝向靶病灶位置。

诊断标准与关键数值

  • 参考标准:良性活检结果以至少24个月随访确立,恶性或交界性结果以手术组织学结果确立。
  • 技术成功定义为MR引导VALB诊断与参考标准一致,达99.5%(859/863)患者和99.7%(1408/1412)可操作靶病灶。
  • 原发技术失败即无法到达靶病灶,发生于0.2%(2/865)患者和0.1%(2/1414)靶病灶。
  • 影像-病理不符提示假阴性活检者占0.5%(4/863)患者和0.3%(4/1412)靶病灶,经二次切除活检确认。

临床应用与阅片要点

  • 每靶病灶至少采集24条组织,活检槽朝向靶病灶,直至活检后控制影像显示病灶完全或至少大部分去除。
  • 失败可能性与病灶位置(中央 vs 外周)、乳腺大小、病灶大小及类型(NME vs ME)均无关。
  • 良性MR引导VALB诊断者随访2年活检部位无乳腺癌发生,无患者出现重大并发症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Magnetic resonance (MR)-guided vacuum-biopsy is technically demanding and may fail depending on target-lesion size or breast size, and location of lesions within the breast. We developed an MR-guided vacuum-assisted biopsy protocol that collects larger amounts of tissue, aiming at an at least partial or complete ablation of the target-lesion, just as it is intended during surgical (excisional) biopsy. Rationale is to avoid biopsy failures (false-negative results due to undersampling) by collecting larger amounts of tissue. We report on our experience with MR-guided vacuum-assisted large-volume breast biopsy (VALB) (MR-guided VALB) with regard to clinical success and complication rates.

MATERIALS: Institutional review board-approved analysis of 865 patients with 1414 MR imaging (MRI)-only breast lesions who underwent tissue sampling under MRI guidance. Magnetic resonance-guided VALB was performed on a 1.5 T-system with a 9G system. Per target lesion, we collected at least 24 samples, with the biopsy notch directed toward the position of the target until on postbiopsy control imaging the target lesion appeared completely or at least greatly removed. The standard-of-reference was established by at least 24-months follow-up (for benign biopsy results), or results of surgical histology (for malignant or borderline results). We investigated the technical success rates as a function of factors that usually interfere with MR-guided vacuum biopsy.

RESULTS: Target lesions were located in the central versus peripheral parts of the breast in 66.6% (941/1414) versus 33.6% (473/1414), occurred in large, intermediate, or small breasts in 22.7% (321/1414), 56.4% (797/1414), or 20.9% (296/1414), corresponded to nonmass enhancement (NME) versus mass enhancement (ME) in 64.0% (905/1414) vs. 36.0% (509/1414), with an average size of 23 mm for NME versus 9 mm for ME, respectively. Primary technical failures, that is, inability to reach the target lesion occurred in 0.2% of patients (2/865) and 0.1% of target lesions (2/1414). Successful biopsy, that is, an MR-guided VALB diagnosis matching with the standard of reference, was achieved in 99.5% (859/863) of patients and 99.7% (1408/1412) target lesions that had been amenable to MR-guided VALB. In 0.5% of patients (4/863) and 0.3% of target lesions (4/1412), a radiologic-pathologic mismatch suggested a false-negative biopsy, confirmed by secondary excisional biopsy. The likelihood of failure was independent of the lesion's location in the breast, breast size, target lesion size, or target lesion type (NME vs ME). None of the patients with benign MR-guided VALB diagnoses developed breast cancer at the biopsy site during follow-up of 2 years. None of the patients developed major complications.

CONCLUSION: Magnetic resonance-guided VALB is a safe procedure that is associated with a high success rate (99.7%) that is independent of the size, type, or location of a target lesion, or the size of the breast, and is associated with a very low complication rate.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Schrading S, Strobel K, Keulers A, et al. Safety and Efficacy of Magnetic Resonance-Guided Vacuum-Assisted Large-Volume Breast Biopsy (MR-Guided VALB). Invest Radiol. 2017. PMID: 27861232. doi:10.1097/RLI.0000000000000331

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。